Financials
- Market Capitalization 11.83 M
- Employee 18
- Founded 2016
- CEO N/A
- Website www.in8bio.com
- Headquarter Delaware, United States
- FIGI BBG00XX9K1M2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.53
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4593 | CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.47 USD | -4.08% | -2.08% | -18.97% | -62.70% | 12.90 M USD | ||
| 4611 | PASG Passage Bio, Inc. - Common Stock | 3.64 USD | -20.00% | -9.45% | -25.71% | -58.82% | 11.71 M USD | ||
| 4616 | ACTU Actuate Therapeutics, Inc. - Common stock | 0.45 USD | -29.69% | -44.44% | -58.33% | -88.97% | 10.81 M USD | ||
| 4619 | PLUR Pluri Inc. - Common Stock | 0.94 USD | -3.09% | -4.08% | -21.01% | -75.41% | 11.60 M USD |